Dan Jacob Gelvan

Dr. Gelvan is a seasoned life-science executive and investor with over thirty years of experience in healthcare. Dan is CEO of t-syte, an early-stage digital health VC venture lab and he is Executive Chairman of Biobeat, Ltd., a leading patient monitoring company. Dan holds a Ph.D. in Business Economics from Roskilde University, Denmark.